HomeNBSE • BMV
add
NeuBase Therapeutics Ord Shs
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.59M | -79.41% |
Net income | -1.82M | 76.14% |
Net profit margin | — | — |
Earnings per share | -1.30 | 74.99% |
EBITDA | -1.46M | 80.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.57M | — |
Total assets | 18.62M | — |
Total liabilities | 9.48M | — |
Total equity | 9.14M | — |
Shares outstanding | 3.73M | — |
Price to book | 20.97 | — |
Return on assets | -19.42% | — |
Return on capital | -25.50% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -1.82M | 76.14% |
Cash from operations | -2.00M | 69.83% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -174.50K | -539.15% |
Net change in cash | -2.18M | 67.48% |
Free cash flow | -2.51M | — |
About
Founded
2009
Website
Employees
37
